ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$26.27
-0.39 (-1.46%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-9.32%
1Y
+82.43%
YTD
-9.41%
Open$26.56
Previous Close$26.66
Day High$27.17
Day Low$26.18
52W High$31.77
52W Low$13.06
Volume—
Avg Volume2.00M
Market Cap3.28B
P/E Ratio—
EPS$-0.02
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.64
Below
SMA 200
$20.38
Above
RSI (14)
67.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+226.5% upside
Current
$26.27
$26.27
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 369.72M | 947.52M | 972.47M |
| Net Income | -15,873,079 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -12,020,511 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |